{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T10:13:49Z","timestamp":1778667229340,"version":"3.51.4"},"reference-count":35,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100017688","name":"Guangdong Provincial Key Laboratory of Construction Foundation","doi-asserted-by":"publisher","award":["Grant2020B1212060034"],"award-info":[{"award-number":["Grant2020B1212060034"]}],"id":[{"id":"10.13039\/501100017688","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173776"],"award-info":[{"award-number":["82173776"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.dmd.2026.100262","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:28:18Z","timestamp":1772497698000},"page":"100262","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["A semimechanistic PK\/PD model\u2013informed Taxus tablets\u2019 development: Accelerating early clinical translation of a taxane-based antitumor agent"],"prefix":"10.1016","volume":"54","author":[{"given":"Yagang","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianyang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guanwen","family":"Mo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuzhen","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haozheng","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Likun","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yonglong","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Long","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiuwen","family":"Wan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daozheng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weichen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haitang","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoping","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2844-5680","authenticated-orcid":false,"given":"Min","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.dmd.2026.100262_bib1","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/9535061","article-title":"Compound Taxus chinensis capsule combined with chemotherapy for non-small-cell lung cancer: a PRISMA-compliant systematic review and meta-analysis of randomized controlled trials","volume":"2021","author":"Li","year":"2021","journal-title":"Evid Based Complement Altern Med"},{"issue":"12","key":"10.1016\/j.dmd.2026.100262_bib2","first-page":"890","article-title":"Research progress on the source, production, and anti-cancer mechanisms of paclitaxel","volume":"18","author":"Yang","year":"2020","journal-title":"Chin J Nat Med"},{"issue":"5","key":"10.1016\/j.dmd.2026.100262_bib3","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.phymed.2015.03.011","article-title":"Pharmacokinetic synergy from the taxane extract of Taxus chinensis improves the bioavailability of paclitaxel","volume":"22","author":"Liu","year":"2015","journal-title":"Phytomedicine"},{"key":"10.1016\/j.dmd.2026.100262_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2021.100754","article-title":"Therapeutic strategies to overcome taxane resistance in cancer","volume":"55","author":"Das","year":"2021","journal-title":"Drug Resist Updates"},{"issue":"17","key":"10.1016\/j.dmd.2026.100262_bib5","first-page":"5210","article-title":"Taxanes in Taxus cuspidata cv. Nana and its anti-tumor activities","volume":"52","author":"Lu","year":"2021","journal-title":"Chin Tradit Herb Drugs"},{"key":"10.1016\/j.dmd.2026.100262_bib6","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.jpba.2015.01.001","article-title":"Simultaneous determination of seven taxoids in rat plasma by UPLC-MS\/MS and pharmacokinetic study after oral administration of Taxus yunnanensis extracts","volume":"107","author":"Liu","year":"2015","journal-title":"J Pharm Biomed Anal"},{"issue":"3","key":"10.1016\/j.dmd.2026.100262_bib7","first-page":"168","article-title":"Effects of flavonoids derived from Taxus yunnanensis on P-glycoprotein and cytochrome P450 3A4","volume":"8","author":"Li","year":"2013","journal-title":"Asian J Pharm Sci"},{"issue":"6","key":"10.1016\/j.dmd.2026.100262_bib8","doi-asserted-by":"crossref","first-page":"6827","DOI":"10.1021\/acsami.9b18443","article-title":"Exploration of the natural active small-molecule drug-loading process and highly efficient synergistic antitumor efficacy","volume":"12","author":"Wang","year":"2020","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.dmd.2026.100262_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.fitote.2013.06.013","article-title":"Comparative pharmacokinetics of paclitaxel after oral administration of Taxus yunnanensis extract and pure paclitaxel to rats","volume":"90","author":"Jin","year":"2013","journal-title":"Fitoterapia"},{"issue":"1\u20132","key":"10.1016\/j.dmd.2026.100262_bib10","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0378-5173(01)00986-3","article-title":"Paclitaxel and its formulations","volume":"235","author":"Singla","year":"2002","journal-title":"Int J Pharm"},{"issue":"2","key":"10.1016\/j.dmd.2026.100262_bib11","doi-asserted-by":"crossref","first-page":"260","DOI":"10.4103\/ijmpo.ijmpo_139_20","article-title":"History of paclitaxel and oral paclitaxel - clinical data and future","volume":"41","author":"Divekar","year":"2020","journal-title":"Indian J Med Paediatr Oncol"},{"issue":"1\u20132","key":"10.1016\/j.dmd.2026.100262_bib12","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.ijpharm.2018.03.030","article-title":"Current development in the formulations of non-injection administration of paclitaxel","volume":"542","author":"Du","year":"2018","journal-title":"Int J Pharm"},{"issue":"17","key":"10.1016\/j.dmd.2026.100262_bib13","first-page":"4020","article-title":"Research progress on non-injection administration systems of paclitaxel","volume":"50","author":"Zhang","year":"2019","journal-title":"Chin Tradit Herb Drugs"},{"issue":"5","key":"10.1016\/j.dmd.2026.100262_bib14","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1093\/annonc\/mdy055","article-title":"Efficacy and safety findings from DREAM: a phase III study of DHP107 (oral paclitaxel) versus i.v. paclitaxel in patients with advanced gastric cancer after failure of first-line chemotherapy","volume":"29","author":"Kang","year":"2018","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.dmd.2026.100262_bib15","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/psp4.12049","article-title":"Good practices in model informed drug discovery and development: practice, application, and documentation","volume":"5","author":"Marshall","year":"2016","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"issue":"8","key":"10.1016\/j.dmd.2026.100262_bib16","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1124\/dmd.108.021592","article-title":"Plasma and urinary tanshinol from Salvia miltiorrhiza (Danshen) can be used as pharmacokinetic markers for cardiotonic pills, a cardiovascular herbal medicine","volume":"36","author":"Lu","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.dmd.2026.100262_bib17","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.phymed.2018.04.041","article-title":"Pharmacokinetic-pharmacodynamic modeling to study the anti-dysmenorrhea effect of Guizhi Fuling capsule on primary dysmenorrhea rats","volume":"48","author":"Cheng","year":"2018","journal-title":"Phytomedicine"},{"key":"10.1016\/j.dmd.2026.100262_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.156716","article-title":"Guiding precision medicine strategy for intravenous ginsenosides via pharmacokinetic-informed bioinformatic approaches: a study on XueShuanTong","volume":"143","author":"Jia","year":"2025","journal-title":"Phytomedicine"},{"issue":"4","key":"10.1016\/j.dmd.2026.100262_bib19","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/cpt.784","article-title":"Poly-pharmacokinetic study of a multicomponent herbal medicine in healthy Chinese volunteers","volume":"103","author":"Xie","year":"2018","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.dmd.2026.100262_bib20","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/3648175","article-title":"Paclitaxel-containing extract exerts anti-cancer activity through oral administration in A549-xenografted BALB\/C nude mice: synergistic effect between paclitaxel and flavonoids or lignoids","volume":"2022","author":"Cai","year":"2022","journal-title":"Evid Based Complement Altern Med"},{"key":"10.1016\/j.dmd.2026.100262_bib21","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J Comput Chem"},{"issue":"3","key":"10.1016\/j.dmd.2026.100262_bib22","first-page":"1","article-title":"Establishment of multidrug resistance gene 1 (Abcb1) knockout and humanized rat models","volume":"25","author":"Ma","year":"2015","journal-title":"Chin J Comp Med"},{"issue":"7","key":"10.1016\/j.dmd.2026.100262_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2025.104417","article-title":"Translational PK\/PD: a retrospective analysis of performance and impact from a drug portfolio","volume":"30","author":"Jansson-L\u00f6fmark","year":"2025","journal-title":"Drug Discov Today"},{"issue":"3","key":"10.1016\/j.dmd.2026.100262_bib24","doi-asserted-by":"crossref","first-page":"e365","DOI":"10.1016\/j.ddtec.2012.07.004","article-title":"Modeling of human tumor xenografts and dose rationale in oncology","volume":"10","author":"Simeoni","year":"2013","journal-title":"Drug Discov Today Technol"},{"key":"10.1016\/j.dmd.2026.100262_bib25","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1158\/1535-7163.MCT-16-0076","article-title":"Combining nonclinical experiments with translational PKPD modeling to differentiate erlotinib and gefitinib","volume":"15","author":"Eigenmann","year":"2016","journal-title":"Mol Cancer Ther"},{"issue":"3","key":"10.1016\/j.dmd.2026.100262_bib26","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1158\/0008-5472.CAN-03-2524","article-title":"Predictive pharmacokinetic-pharmacodynamic modeling of tumor growth kinetics in xenograft models after administration of anticancer agents","volume":"64","author":"Simeoni","year":"2004","journal-title":"Cancer Res"},{"issue":"4","key":"10.1016\/j.dmd.2026.100262_bib27","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.3390\/cancers7040897","article-title":"Paclitaxel through the ages of anticancer therapy: exploring its role in chemoresistance and radiation therapy","volume":"7","author":"Barbuti","year":"2015","journal-title":"Cancers"},{"key":"10.1016\/j.dmd.2026.100262_bib28","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00280-009-1153-z","article-title":"Preclinical pharmacokinetic\/pharmacodynamic models to predict synergistic effects of coadministered anti-cancer agents","volume":"66","author":"Goteti","year":"2010","journal-title":"Cancer Chemother Pharmacol"},{"issue":"12 Pt 1","key":"10.1016\/j.dmd.2026.100262_bib29","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1158\/1535-7163.MCT-07-0261","article-title":"Efficacy and tissue distribution of DHP107, an oral paclitaxel formulation","volume":"6","author":"Hong","year":"2007","journal-title":"Mol Cancer Ther"},{"issue":"3","key":"10.1016\/j.dmd.2026.100262_bib30","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jddst.2018.09.014","article-title":"Effect of paclitaxel content in the DHP107 oral formulation on oral bioavailability and antitumor activity","volume":"8","author":"Jang","year":"2018","journal-title":"J Drug Deliv Sci Technol"},{"issue":"5","key":"10.1016\/j.dmd.2026.100262_bib31","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/s41419-021-03771-z","article-title":"Cephalomannine inhibits hypoxia-induced cellular function via the suppression of APEX1\/HIF-1\u03b1 interaction in lung cancer","volume":"12","author":"Ullah","year":"2021","journal-title":"Cell Death Dis"},{"issue":"4","key":"10.1016\/j.dmd.2026.100262_bib32","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1021\/acs.jnatprod.7b00006","article-title":"\u03b1-Glucosidase inhibitory and cytotoxic taxane diterpenoids from the stem bark of Taxus wallichiana","volume":"80","author":"Dang","year":"2017","journal-title":"J Nat Prod"},{"issue":"2","key":"10.1016\/j.dmd.2026.100262_bib33","first-page":"297","article-title":"Cephalomannine and 10-deacetyltaxol cytotoxicity in human glial and neuroblastoma cell-lines","volume":"2","author":"Helson","year":"1993","journal-title":"Int J Oncol"},{"issue":"1","key":"10.1016\/j.dmd.2026.100262_bib34","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.vascn.2005.12.004","article-title":"Development and characterization of LLC-PK1 cells containing Sprague-Dawley rat Abcb1a (Mdr1a): comparison of rat P-glycoprotein transport to human and mouse","volume":"54","author":"Booth-Genthe","year":"2006","journal-title":"J Pharmacol Toxicol Methods"},{"issue":"2","key":"10.1016\/j.dmd.2026.100262_bib35","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s40272-018-0282-4","article-title":"The relationship between vancomycin trough concentrations and AUC\/MIC ratios in pediatric patients: a qualitative systematic review","volume":"20","author":"Tkachuk","year":"2018","journal-title":"Paediatr Drugs"}],"updated-by":[{"DOI":"10.1016\/j.dmd.2026.100316","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000}}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955626000310?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955626000310?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T09:29:29Z","timestamp":1778664569000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955626000310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S0090955626000310"],"URL":"https:\/\/doi.org\/10.1016\/j.dmd.2026.100262","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A semimechanistic PK\/PD model\u2013informed Taxus tablets\u2019 development: Accelerating early clinical translation of a taxane-based antitumor agent","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dmd.2026.100262","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"100262"}}